Amplia Therapeutics Limited (ASX:ATX)
Share Pricing & News Healthcare

AUD 0.086

-0.004 (4.444%)
(As on 2023-02-04 12:55:21 AEDT)
Previous Close Open Close*
0.09 0.086 0.086
Market Cap Dividend Yield (Annualized)
AUD 16.684M 0.00%

Day Range
0.086L 0.086 H
52 WEEK HIGH LOW
0.08L 0.18 H

Chart Price & Information

Last Trade 0.086
Change% -4.4444
52 W H/L 0.180/0.080
EBITDA -4.423M
NPAT After Abnormal Items -3.644M
Equity 21.848M
ROE% -16.68%
Total Liabilities 2.636M
Total Revenue 1.983M
Cash and Cash Equivalents 14.609M

Stock Information

Share price 0.086
Market Cap 16.684M
Price/Gross Cash Flow -11.03
Dividend Yield Excluding Special 0.00%
Ending Shares 193.854M
52-Week Range 0.180-0.080
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.07
P/E ratio 0.000
Sector P/E --
EPS -2.50
EV/EBITDA --
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.02
Net Gearing -57.25%
Sales Per Share 0.00
Book Value Per Share 0.11

Similar Companies

Related Articles

About Company

Amplia Therapeutics Limited is based in Melbourne, Australia. It is engaged with the development of FAK (Focal Adhesion Kinase) for the treatment of diseases like cancer and fibrosis. FAK is positioning itself as a significant pick in the cancer immunology and Amplia. Some of the company’s drug candidate include- AMP945 & AMP886.

Corporate Information


Level 21, 90 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000

Phone:(02) 8003 3650

Website:http://www.ampliatx.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-11-17 2023
Report (Annual) 2023-05-29 2023
Report (Prelim) 2023-05-29 2023